Literature DB >> 670382

Diagnosis of California La Crosse virus infection by counterimmunoelectrophoresis.

H S Lindsey, W H Thompson, J F Obijeski.   

Abstract

La Crosse virus cell culture-derived soluble antigen was used in a counterimmunoelectrophoresis procedure to assess the presence or absence of La Crosse antibodies in 79 paired acute- and convalescent-phase human sera. The counterimmunoelectrophoresis test appeared to measure the same antibody as the complement fixation test but was more sensitive and rapid.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 670382      PMCID： PMC275084          DOI： 10.1128/jcm.7.6.603-608.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.

Authors:  W H THOMPSON; B KALFAYAN; R O ANSLOW
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

2.  Serum dilution neutralization test for California group virus identification and serology.

Authors:  H S Lindsey; C H Calisher; J H Mathews
Journal:  J Clin Microbiol       Date:  1976-12       Impact factor: 5.948

Review 3.  Bunyaviridae: recent biochemical developments.

Authors:  J F Obijeski; F A Murphy
Journal:  J Gen Virol       Date:  1977-10       Impact factor: 3.891

4.  Arbovirus identification by an agar-gel diffusion technique.

Authors:  C H Calisher; K S Maness
Journal:  Appl Microbiol       Date:  1970-04

5.  California group arboviruses: immunodiffusion studies.

Authors:  F A Murphy; P H Coleman
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

6.  La Crosse virus soluble cell culture antigen.

Authors:  H S Lindsey; R A Klimas; J F Obijeski
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

7.  California arbovirus (La Crosse) infections. II. Precipitin antibody tests for the diagnosis of California encephalitis.

Authors:  H H Balfour; R J Majerle; C K Edelman
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.